• Transiently Altered Distribution of F-18 FDG in a Patient with Subacute Thyroiditis

• Kim Myoung-Hyoun

• Kim Dae-Weung, Park Soon-Ah, Kim Chang-Guhn

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 82 ~ 84

• Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: ...

• Baum Richard P.

• Langbein Thomas, Singh Aviral, Shahinfar Mostafa, Schuchardt Christiane, Volk Gerd Fabian, Kulk...

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 80 ~ 81

• Systemic Lupus Erythematosus Associated Pitfalls on 18F-FDG PET/CT: Reactive Follicular Hyperplasia,...

• Makis William

• Ciarallo Anthony, Gonzalez-Verdecia Milene, Probst Stephan

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 74 ~ 79

• Primary Renal Leiomyosarcoma Presenting with Subcutaneous and Osseous Metastases: Staging and Follow...

• Makis William

• Brimo Fadi, Probst Stephan

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 69 ~ 73

• Multiple Regression Analysis of Predictors of Bone Scintigraphy Positivity in Patients with Head and...

• Theerakulpisut Daris

• Wongsurawat Nantaporn, Supakalin Narudom, Somboonporn Charoonsak

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 62 ~ 68

• The Utility of FDG PET/CT in IgG4-Related Disease with a Focus on Coronary Artery Involvement

• Huang Hian L

• Fong Warren, Peh Wee M, Niraj Kasat A, Lam Winnie W

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 53 ~ 61

• Correlation of FDG PET/CT Findings with Long-Term Growth and Clinical Course of Abdominal Aortic Ane...

• Lee Hyun-Jong

• Paeng Jin-Chul, Kim Kyung-Hwan, Cheon Gi-Jeong, Lee Dong-Soo, Chung June-Key, Kang Keon-Wook

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 46 ~ 52

• Evaluation of 18F-FDG PET/CT Parameters for Detection of Lymph Node Metastasis in Cutaneous Melanoma

• Cha Jong-Tae

• Kim So-Young, Wang Ji-Young, Yun Mi-Jin, Cho Arthur

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 39 ~ 45

• Prognostic Value of Pre- and Post-Treatment FDG PET/CT Parameters in Small Cell Lung Cancer Patients

• Kim Hyoung-Woo

• Yoo Ie-Ryung, Boo Sun-Ha, Park Hye-Lim, O Joo-Hyun

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 31 ~ 38

• Development of tau PET Imaging Ligands and their Utility in Preclinical and Clinical Studies

• Choi Yoo-Ri

• Ha Seung-Gyun, Lee Yun-Sang, Kim Yun-Kyung, Lee Dong-Soo, Kim Dong-Jin

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 24 ~ 30

• Obesity and Brain Positron Emission Tomography

• Pak Kyoung-June

• Kim Seong-Jang, Kim In-Joo

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 16 ~ 23

• Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Bette...

• Im Hyung-Jun

• Bradshaw Tyler, Solaiyappan Meiyappan, Cho Steve Y.

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 5 ~ 15

• PERCIST in Perspective

• O Joo-Hyun

• Wahl Richard L.

• Nuclear Medicine and Molecular Imaging   2018  Volume.52  No.1 1 ~ 4